Russian Federation
Russian Federation
Russian Federation
VAC 14.02.2004 Медицина труда
UDK 61 Медицина. Охрана здоровья
GRNTI 76.29 Клиническая медицина
OKSO 31.08.71 Организация здравоохранения и общественное здоровье
BBK 53 Клиническая медицина в целом
BBK 58 Прикладные отрасли медицины
TBK 5734 Медицинская радиология и рентгенология
BISAC MED080000 Radiology, Radiotherapy & Nuclear Medicine
BISAC SCI058000 Radiation
This study quantitatively compares 239Pu microdistribution in lung of two deceased former Mayak PA workers who were exposed to 239Pu by inhalation and two deceased subject who had been never employed at Mayak PA. The comparison is made utilizing neutron-activation method of measurement. The results are compared to the results of less-sensitive autoradiographic method. The study demonstrated that the most of 239Pu activity in lung is concentrated in areas of interstitial sclerosis.
Plutonium-239, neutron-activation measurement method, track detectors, nanoparticles, microdistribution, Anatomical regions of the lung, Mayak PA, personnel
1. Ryabukhin YuS. Low levels of ionizing radiation and health: a Systematic approach (Analytical review). Medical Radiology. 2000;(4):5-45. (In Russ.).
2. Khokhryakov VV, Nekrasov KA. On the mechanism of formation of plutonium dioxide nanoparticles. Radiation Safety Issues. 2015(1):55-68. (In Russ.).
3. Khokhryakov VV, Sypko CA. Studies of the dispersed composition of alpha-emitting aerosols in the air of the working premises of the PA Mayak. Radiation Safety Issues. 2019(4):73-80. (In Russ.).
4. Sypko SA, Vvedensky VE, Bobov GN. Studies of statistical characteristics of the size distribution of 239PuO2 nanoparticles in the air of the oxalate deposition Department of the PA Mayak fuel recovery plant using a neutron-induced measurement method. Radiation Safety Issues. 2019(2):71-9. (In Russ.).
5. Sturm R. Radioactivity and lung cancer-mathematical models of radionuclide deposition in the human lungs. J Thorac Dis. 2011;3:231-43. DOI:https://doi.org/10.3978/j.issn.2072-1439.2011.04.01.
6. Fleischer RL, Raabe OG. On the Mechanism of “Dissolution” in Liquids of PuO2 by Alpha Decay. Health Phys. October 1978;35:545-8.
7. Fleischer RL, Raabe OG. Fragmentation of respirable PuO2 particles in Water by Alpha Decay-a Mode of “Dissolution”. Health Phys. April 1977;32:253-7.
8. Method for performing measurements of plutonium-239 contained in industrial alpha-emitting nanoparticles. Certificate of certification of radiation control methods № 4390.2.P397 27.09.2012. FR.1.38.2012.13346. (In Russ.).
9. Khokhryakov VV, Vvedensky VE, Sypko SA, Bobov GN, Korpachev AB, Khokhryakov IV. Results of research on the development of a neutron-induced method for measuring the size of 239Pu dioxide nanoparticles. Radiation Safety Issues. 2014;(3):69-81. (In Russ.).
10. Vvedensky VE, Sypko SA, Bobov GN. Improvement of the neutron-induced method for measuring the size of 239Pu dioxide nanoparticles. ANRI. 2019;(2):79-90. (In Russ.).
11. Vvedensky VE, Sypko SA, Bobov GN. Determination of the diameter of the 239PuO2 nanoparticle using the neutron-induced method and calculation of the standard uncertainty of the nanoparticle diameter. ANRI. 2019;(4):38-50. (In Russ.).
12. Romanov SA. Microdistribution of plutonium in lungs as a basis for correction of dosimetric models. Biol. Sci. Moscow. 2003. 113 p. (In Russ.).
